Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trials

Medical device clinical trials from ClinicalTrials.gov

Trial SUSPENDED

A Clinical Study of EUS-RFA for Inoperable Pancreatic Ductal Adenocarcinoma

NCT NCT03444948

Start 2019-02-14

View Details →

Trial RECRUITING

S-FLEX Netherlands Registry: Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System

NCT NCT03443999

Start 2018-02-27

View Details →

Trial ENROLLING_BY_INVITATION

Prospective Use of Philips iSuite for Interventional Procedures

NCT NCT03432936

Start 2021-06-01

View Details →

Trial ACTIVE_NOT_RECRUITING

Neural Enabled Prosthesis for Upper Limb Amputees

NCT NCT03432325

Start 2017-12-14

View Details →

Trial ACTIVE_NOT_RECRUITING

Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia

NCT NCT03431090

Start 2018-03-02

View Details →

Trial ACTIVE_NOT_RECRUITING

Comprehensive Nano - Post Market Clinical Follow-Up Study

NCT NCT03423953

Start 2013-10-30

View Details →

Trial COMPLETED

Post Operative Pain After Laparoscopic Hysterectomy Using Airseal® Versus Standard Insufflation System

NCT NCT03418402

Start 2018-02-08

View Details →

Trial COMPLETED

Feasibility of the Menstrual Cup for VVF

NCT NCT03414060

Start 2016-08-08

View Details →

Trial ACTIVE_NOT_RECRUITING

Virtual E-health System for Implantable Cardioverter Defibrillators

NCT NCT03405740

Start 2020-05-01

View Details →

Trial WITHDRAWN

The Mount Sinai Diabetic Foot Ulcer Prospective Trial

NCT NCT03404895

Start 2018-04-13

View Details →

Trial COMPLETED

Medacta GMK Sphere® vs. Medacta GMK PS Post-Market Outcomes Study

NCT NCT03391323

Start 2015-04

View Details →

Trial ACTIVE_NOT_RECRUITING

High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

NCT NCT03389347

Start 2018-02-14

View Details →

Page 769 of 784

↑